• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Metronidazole: Required Treatment for Hemorrhagic Diarrhea?

November 28, 2018
Natalie Stilwell, DVM, MS, PhD

A recent study suggests that amoxicillin with clavulanic acid is just as effective as combination therapy with metronidazole.

Amoxicillin, often with clavulanic acid, is a frequently prescribed antibiotic for bacterial diarrhea in canine patients due to its broad-spectrum coverage. Metronidazole is also administered commonly; however, potential risks associated with its use in small animals include toxicity, bacterial translocation, and development of drug-resistant Escherichia coli.

In a recent study published in Journal of Small Animal Practice, investigators from the United Kingdom compared the efficacy of amoxicillin—clavulanic acid therapy with and without the addition of metronidazole for treatment of acute hemorrhagic diarrhea.

Methods

Enrolled dogs included client-owned pets hospitalized for acute, profuse, bloody diarrhea lasting fewer than 3 days. Cases were excluded if they had concurrent renal or liver disease or had received antibiotics within the previous 3 days. On admission, dogs were assigned randomly to 1 of 2 treatment categories, to which attending clinicians and nurses were blinded.

All dogs received the following:

  • Intravenous (IV) fluid therapy
  • 8.75 mg/kg amoxicillin—clavulanic acid every 8 hours
  • Buprenorphine as needed for analgesia
Advertisement
  • Daily omeprazole for gastroprotection
  • Daily maropitant as needed for nausea or vomiting

Dogs in the treated group also received 10 mg/kg IV metronidazole every 12 hours, while those in the placebo group received an equivalent volume of saline.

Treatment efficacy was assessed by 2 means. First, duration of hospitalization was measured from the time of admission to when the patient was approved for discharge. Second, a clinical scoring system was used to evaluate patient progress. In this method, a blinded observer retrospectively examined patient hospitalization charts to assign daily scores for appetite, vomiting, stool frequency, stool consistency, and administered rate of IV fluid therapy.

Results

Thirty-four dogs that were hospitalized for acute hemorrhagic diarrhea completed the trial over a 24-month period. Participating dogs ranged from 4 months to over 13 years in age, and a wide range of weights and breeds were represented. Seventy percent of dogs were male. Dehydration was recorded in all dogs, but none were pyrexic.

Twenty of 34 dogs were assigned randomly to the treatment group receiving metronidazole in addition to amoxicillin—clavulanic acid and supportive care. No side effects from metronidazole were noted in any dogs.

RELATED:

  • Immune-Stimulating Properties of Antibiotics
  • Multidrug-resistant Infections in Veterinary Clinics

Duration of hospitalization was similar for dogs in both treatment groups. Those receiving the standard supportive treatment and amoxicillin—clavulanic acid had a mean hospital stay of 26.3 hours, while those administered standard treatment plus metronidazole were hospitalized for a mean of 29.6 hours. Likewise, daily clinical scores were similar in the 2 groups, and both groups generally showed significant clinical improvement after 24 hours of hospitalization. A single dog in each treatment group had recurring clinical signs after discharge that necessitated continued treatment for diarrhea.

Conclusion

The authors suggested that metronidazole is not a necessary component of treatment for bacterial gastroenteritis in dogs. They also recommended limited use of metronidazole in general, due to increasing evidence of metronidazole resistance in bacteria isolated from humans and animals, including Clostridium.

Dr. Stilwell received her DVM from Auburn University, followed by a MS in fisheries and aquatic sciences and a PhD in veterinary medical sciences from the University of Florida. She provides freelance medical writing and aquatic veterinary consulting services through her business, Seastar Communications and Consulting.


Advertisement

Latest News

The Vets appoints Dr Zach Mills to VP of Medical Performance

Communicating the importance of genetic screening

Purina announces its 2023 Pet Care Innovation Prize winners

AmeriVet Veterinary Partners deemed a 2022 Business of the Year

View More Latest News
Advertisement